Sumi H, Maruyama M, Yoneta T, Mihara H
Acta Haematol. 1983;70(5):289-95. doi: 10.1159/000206755.
Following intrarectal administration of high molecular weight urokinase (molecular weight 53,000; 124,000 IU/mg protein) and its functionally active heavy chain (molecular weight 31,000; 212,000 IU/mg protein) to mice, activation of plasma fibrinolysis was observed. The plasma levels of pyro-Glu-Gly-Arg-pNA amidolysis and euglobulin fibrinolytic activities reached a maximum (43.4 +/- 5.3 nmol/ml and 10.8 +/- 9.4 mm2/0.03 ml, respectively) at 1-2 h after the administration of 300 IU of either enzyme per mouse, and thereafter, both activities declined slowly. Urokinase absorption into the plasma was further confirmed from the immunoreactivity of plasma enzymes isolated by affinity chromatography to each anti-urokinase serum.
给小鼠直肠内注射高分子量尿激酶(分子量53,000;212,000国际单位/毫克蛋白质)及其功能活性重链(分子量31,000;212,000国际单位/毫克蛋白质)后,观察到血浆纤维蛋白溶解被激活。每只小鼠注射300国际单位任一种酶后1 - 2小时,血浆焦谷氨酸 - 甘氨酸 - 精氨酸 - 对硝基苯胺酰胺水解活性和优球蛋白纤维蛋白溶解活性水平达到最高(分别为43.4±5.3纳摩尔/毫升和10.8±9.4平方毫米/0.03毫升),此后,两种活性均缓慢下降。通过亲和层析分离的血浆酶与每种抗尿激酶血清的免疫反应性进一步证实了尿激酶被吸收进入血浆。